THC May Treat Spasticity and Pain Associated with Multiple Sclerosis, According to New Research

The oral administration of Δ9-tetrahydrocannabinol (THC) may treat both spasticity and pain associated with multiple sclerosis.

Multiple SclerosisThis is according to a study being published by the journal Clinical Therapeutics, and e-published ahead of print by the U.S. National Institute of Health.

According to the Mayo Clinic, multiple sclerosis (MS) is a “disease in which the immune system eats away at the protective covering of nerves.” The ailment affects around 200,000 people annually and has no cure. Multiple sclerosis causes many different symptoms, including vision loss, pain, fatigue, and impaired coordination.

The aim of the present study was to “evaluate the efficacy of an oral formulation of Δ9-tetrahydrocannabinol (ECP002A) in patients with progressive multiple sclerosis (MS).”

Read moreTHC May Treat Spasticity and Pain Associated with Multiple Sclerosis, According to New Research

Study: Cannabinoids a Safe and Effective Treatment for Tourette syndrome

Tourette syndromeCannabinoids are a safe and effective treatment for Tourette syndrome, a new study published in the journal Australian Psychiatry has found. According to the Mayo Clinic Tourette syndrome is a nervous system disorder that often involves “uncontrollable repetitive movements or unwanted sounds (tics), such as repeatedly blinking the eyes, shrugging shoulders, or blurting out offensive words.”

For the study, a subject “received 10.8 mg Tetrahydocannabinol and 10 mg cannabidiol daily, in the form of two oro-mucosal sprays of ‘Sativex®‘, twice daily. Assessment was pre-treatment and at week one, two, and four during treatment.”

Researchers say that “Both subjective and objective measures demonstrated marked improvement in the frequency and severity of motor and vocal tics post-treatment. There was good interrater reliability of results.”

Read moreStudy: Cannabinoids a Safe and Effective Treatment for Tourette syndrome